WP Advisors LLC reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 77.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,092 shares of the exchange traded fund’s stock after selling 10,452 shares during the quarter. WP Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $305,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF in the third quarter worth $40,000. ORG Partners LLC purchased a new position in SPDR S&P Biotech ETF in the second quarter worth $40,000. ORG Wealth Partners LLC purchased a new position in SPDR S&P Biotech ETF in the third quarter worth $44,000. Waldron Private Wealth LLC purchased a new position in SPDR S&P Biotech ETF in the third quarter worth $54,000. Finally, Resources Management Corp CT ADV grew its holdings in SPDR S&P Biotech ETF by 30.3% in the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares during the last quarter.
SPDR S&P Biotech ETF Trading Down 5.3 %
NYSEARCA XBI opened at $91.83 on Monday. The firm’s fifty day simple moving average is $98.95 and its two-hundred day simple moving average is $96.17. SPDR S&P Biotech ETF has a 12-month low of $69.32 and a 12-month high of $105.47. The firm has a market capitalization of $7.00 billion, a P/E ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- What is a Special Dividend?
- Time to Buy These Up-and-Coming Software Firms?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Alibaba Stock: Why Earnings Make It a Buy Despite the Recent Dip
- Health Care Stocks Explained: Why You Might Want to Invest
- Plug Power Stock: Mixed Results Adds To Volatilty
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.